Clinical Trials Browser

Locally Advanced Rectal Cancer × camrelizumab × 90 days × Clear all

NCT07527026 2026-04-14

A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer

Phase 2 Recruiting

Gastrointestinal

Locally Advanced Rectal Cancer